Lesion and ulcer medication
First Claim
1. A mucoadhesive pharmaceutical composition for treatment of intraoral ulcers comprising an antimicrobial component, dexamethasone, and diphenhydramine, whereinthe antimicrobial component comprises between 25 and 95 weight percent of the active ingredients, the dexamethasone comprises between 0.02 and 0.75 weight percent of the active ingredients, and the diphenhydramine comprises between 0.45 and 11 weight percent of the active ingredients.
0 Assignments
0 Petitions
Accused Products
Abstract
Pharmaceutical compositions are provided which comprise effective amounts of antimicrobials, anti-inflammatories, and antihistamines, to provide an ulcer medication which prevents secondary infections and promotes healing while providing immediate relief from pain. The composition may be used to treat a variety of ulcers including but not limited to intraoral aphthous ulcers and non-oral lesions.
-
Citations
14 Claims
-
1. A mucoadhesive pharmaceutical composition for treatment of intraoral ulcers comprising an antimicrobial component, dexamethasone, and diphenhydramine, wherein
the antimicrobial component comprises between 25 and 95 weight percent of the active ingredients, the dexamethasone comprises between 0.02 and 0.75 weight percent of the active ingredients, and the diphenhydramine comprises between 0.45 and 11 weight percent of the active ingredients.
- 12. A mucoadhesive pharmaceutical composition for treatment of intraoral ulcers comprising 500 parts tetracycline HCl, 1 part dexamethasone, 17 parts diphenhydramine, and 67 parts zinc oxide.
Specification